MXCT
MaxCyte, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website maxcyte.com
- Employees(FY) 125
- ISIN US57777K1060
Performance
-1.27%
1W
+17.04%
1M
-1.06%
3M
+19.74%
6M
-0.64%
YTD
+22.57%
1Y
Profile
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Investment Analysis Report: MXCT
Overview
MXCT operates in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $489.51 million. In this report, we will conduct a comprehensive analysis of MXCT's financial statements to evaluate its valuation, financial health, earnings and revenue ...
Technical Analysis of MXCT 2024-05-10
Overview:
In analyzing the technical indicators for MXCT over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...
Recent News & Updates
- 2024-05-12 08:19
MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-08 14:39
MaxCyte Shares Rise Sharply After Q1 Results Beat(MT Newswires)
- 2024-05-07 18:35
Q1 2024 MaxCyte Inc Earnings Call(Yahoo Finance)
- 2024-05-07 17:45
- 2024-05-07 16:05
- 2024-05-07 15:58
- 2024-05-07 08:58
- 2024-05-07 05:45
- 2024-05-07 04:05
- 2024-04-17 04:35
We Think MaxCyte (LON:MXCT) Can Afford To Drive Business Growth(Simply Wall St.)
- 2024-04-10 08:05
- 2024-04-09 20:05
- 2024-04-02 08:05
- 2024-04-01 20:05
- 2024-03-17 04:24
- 2024-03-14 09:41
- 2024-03-14 08:15
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript(Insider Monkey)
- 2024-03-13 20:15
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript(Insidermonkey)
- 2024-03-13 08:40
- 2024-03-12 20:17
11 Oversold Healthcare Stocks To Buy Right Now(Yahoo Finance)
- 2024-03-12 16:05
- 2024-03-12 05:31
- 2024-03-12 04:05
- 2024-03-04 16:05
- 2024-03-04 03:05
- 2024-02-09 08:05
- 2024-02-08 19:05
- 2024-01-29 19:05
- 2024-01-23 08:05
- 2024-01-22 19:05
Page 1 of 5
previousnext